Summary: A new study reveals that psilocybin, the active compound in magic mushrooms, temporarily disrupts brain networks involved in introspective thinking, like daydreaming and memory. These changes persist for weeks,…
Category: psychedelics
Surge in Microdosing Interest Linked to Relaxed Drug Policies
Summary: A new study reveals a 1250% increase in Google searches for micro dosing from 2015 to 2023, driven by relaxed regulations on cannabis and psychedelics. The research shows policy…
MDMA Variants Show Promise for Safer Psychotherapy
Summary: Researchers developed three new MDMA variants (ODMA, TDMA, and SeDMA) that retain the therapeutic benefits while reducing side effects. These compounds affect mood-regulating brain structures similarly to MDMA but…
Unraveling Psychedelics’ Potential in Mental Health
Summary: Research delves into the potential of psychedelics like psilocybin for treating psychiatric disorders. Studies show varying effects of psilocybin on fear learning in rats and mice, dependent on sex…
Psilocybin Microdosing Promising for Mental Health Disorders
Summary: Researchers delve into the therapeutic potential of psilocybin microdosing, exploring its influence on stress resilience and compulsive behaviors in rats. While high-dose psilocybin therapy has been scrutinized for psychiatric…
Psychedelics Sync Neurons: A Glimpse into Consciousness & Psychosis
Summary: Researchers have pioneered a method to simultaneously measure electrical signals from 128 brain regions in conscious rats. Using this technique, they observed the effects of psychedelic drugs, LSD and…
Journeys Beyond: Contrasting Psychedelic Trips and Near-Death Experiences
Summary: A research study scrutinizes the parallels and differences between a near-death experience (NDE) during a coma and the experience induced by a potent psychedelic drug, 5-Methoxy-DMT (5MeO-DMT). The researchers…
